Abstract
Background/Objectives: Obstructive sleep apnea (OSA) is diagnosed using pulse oximetry, which is less accurate in patients with darker skin. Two hypopnea definitions are in use: the American Academy of Sleep Medicine allows either (A) a 30% airflow decrease with a 3% oxygen desaturation or EEG arousal ("3% Rule") or (B) a 30% airflow decrease with a 4% oxygen desaturation ("4% Rule"). The Centers for Medicare and Medicaid Services and many payers use only the 4% Rule. We hypothesized that patients from racial minority groups with darker skin tones would be less likely to qualify for OSA treatment using the 4% Rule compared to the 3% Rule. A secondary aim was to examine sex disparities. Methods: We reviewed records of adults undergoing overnight sleep studies at an urban academic hospital. Demographics, medical history, and comorbidities were collected. Analyses controlled for age, sex, BMI, anxiety, depression, hypertension, COPD, and smoking. Results: A total of 1354 records were analyzed. We found no racial or sex disparities in the proportion of participants who met the 3% but not the 4% Rule. After controlling for covariates, no racial group differed from White participants in meeting only the 3% Rule. However, female participants were significantly less likely than males to meet the 4% Rule. Conclusions: Despite known limitations of pulse oximetry associated with skin tone, no racial differences in the diagnosis of OSA were seen in this cohort. However, female patients had lower odds of meeting the 4% Rule, suggesting a potential barrier to treatment.